Protara Therapeutics, Inc. (TARA)

NASDAQ: TARA · IEX Real-Time Price · USD

2.030

-0.060 (-2.87%)

At close: Jul 2, 2024, 4:00 PM

1.980

-0.050 (-2.46%)

After-hours: Jul 2, 2024, 4:28 PM EDT

Protara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2013
Market Capitalization	42	21	30	76	271	8	Upgrade
Market Cap Growth	29.55%	-29.43%	-60.18%	-72.06%	3280.30%	-81.60%	Upgrade
Enterprise Value	-8	-39	-48	-8	104	7	Upgrade
PE Ratio	-	-0.53	-0.46	-1.60	-7.99	-1.03	Upgrade
PB Ratio	0.72	0.31	0.30	0.47	1.36	-3.77	Upgrade
P/FCF Ratio	-1.31	-0.57	-1.14	-2.16	-11.17	-1.46	Upgrade
P/OCF Ratio	-1.31	-0.57	-1.14	-2.20	-11.60	-1.60	Upgrade
EV/EBITDA Ratio	0.10	0.97	0.73	0.17	-3.07	-0.96	Upgrade
EV/EBIT Ratio	0.10	0.96	0.72	0.17	-3.06	-0.95	Upgrade
EV/FCF Ratio	0.12	1.03	1.80	0.23	-4.28	-1.36	Upgrade
Debt / Equity Ratio	0.09	0.08	0.06	0.04	0.01	-	Upgrade
Debt / EBITDA Ratio	-0.12	-0.14	-0.10	-0.15	-0.03	-	Upgrade
Debt / FCF Ratio	-0.15	-0.15	-0.24	-0.21	-0.04	-	Upgrade
Quick Ratio	10.04	10.67	14.70	21.23	57.86	0.17	Upgrade
Current Ratio	10.53	11.17	15.01	21.66	58.13	0.23	Upgrade
Interest Coverage	-	-	-	-	-998.35	-	Upgrade
Return on Equity (ROE)	-58.80%	-49.70%	-48.90%	-27.00%	-26.20%	-104.10%	Upgrade
Return on Assets (ROA)	-51.40%	-43.80%	-45.60%	-25.70%	-25.40%	-77.30%	Upgrade
Return on Capital (ROIC)	-71.87%	-59.11%	-61.83%	-28.07%	-17.19%	367.95%	Upgrade
Earnings Yield	-101.61%	-189.67%	-218.41%	-62.30%	-12.52%	-97.51%	Upgrade
FCF Yield	-83.94%	-176.45%	-88.01%	-46.28%	-8.95%	-68.32%	Upgrade
Buyback Yield / Dilution	-1.04%	-0.64%	-0.24%	-55.28%	-180.66%	-469.54%	Upgrade
Total Shareholder Return	-1.04%	-0.64%	-0.24%	-55.28%	-180.66%	-469.54%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).